Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Y Chang

Showing results (121-130 of 312) with videos related to

Pageof 32
Sort By:
JAMA Surgery|October 17, 2014
Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderlyShervin M Shirvani, Jing Jiang, Joe Y Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer OligometastasesVivek Verma, Nikhil Yegya-Raman, Tanja Sprave, et al.
Cancer|June 27, 2013
Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancerJoe Y Chang, Yung-Hsien Liu, Zhengfei Zhu, et al.
Anticancer Research|December 30, 2023
Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical TrialMolly K Tate, Mike Hernandez, Joe Y Chang, et al.
Radiation Oncology (London, England)|September 12, 2012
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancerJoe Y Chang, Hui Liu, Peter Balter, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2012
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderlyShervin M Shirvani, Jing Jiang, Joe Y Chang, et al.
Seminars in Oncology|July 15, 2005
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapyRitsuko Komaki, Joe Y Chang, Xifeng Wu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2014
Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indicationsQiaoqiao Li, Cameron W Swanick, Pamela K Allen, et al.
Cancer|March 26, 2011
Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancerJoe Y Chang, Ritsuko Komaki, Charles Lu, et al.
Cancer|December 13, 2005
Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinomaCharles Lu, Margaret R Spitz, Hua Zhao, et al.
Pageof 32

Showing results (121-130 of 312) with videos related to

Sort By:
Pageof 32
JAMA Surgery|October 17, 2014
Lobectomy, sublobar resection, and stereotactic ablative radiotherapy for early-stage non-small cell lung cancers in the elderlyShervin M Shirvani, Jing Jiang, Joe Y Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2022
A Systematic Review of the Cost-Effectiveness of Stereotactic Radiation Therapy for Cancer OligometastasesVivek Verma, Nikhil Yegya-Raman, Tanja Sprave, et al.
Cancer|June 27, 2013
Stereotactic ablative radiotherapy: a potentially curable approach to early stage multiple primary lung cancerJoe Y Chang, Yung-Hsien Liu, Zhengfei Zhu, et al.
Anticancer Research|December 30, 2023
Metformin in Conjunction With Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer: Long-term Results of a Prospective Phase II Clinical TrialMolly K Tate, Mike Hernandez, Joe Y Chang, et al.
Radiation Oncology (London, England)|September 12, 2012
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancerJoe Y Chang, Hui Liu, Peter Balter, et al.
International Journal of Radiation Oncology, Biology, Physics|September 15, 2012
Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderlyShervin M Shirvani, Jing Jiang, Joe Y Chang, et al.
Seminars in Oncology|July 15, 2005
Mutagen sensitivity may predict lung protection by amifostine for patients with locally advanced non-small cell lung cancer treated by chemoradiotherapyRitsuko Komaki, Joe Y Chang, Xifeng Wu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2014
Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indicationsQiaoqiao Li, Cameron W Swanick, Pamela K Allen, et al.
Cancer|March 26, 2011
Phase 2 study of high-dose proton therapy with concurrent chemotherapy for unresectable stage III nonsmall cell lung cancerJoe Y Chang, Ritsuko Komaki, Charles Lu, et al.
Cancer|December 13, 2005
Association between glutathione S-transferase pi polymorphisms and survival in patients with advanced nonsmall cell lung carcinomaCharles Lu, Margaret R Spitz, Hua Zhao, et al.
Pageof 32